Abstract / Description of output
Acute liver failure (ALF) is a relatively uncommon but dramatic clinical syndrome with high mortality rates, in which a previously normal liver fails within days or weeks. Paracetamol overdose remains the major cause of ALF in the UK, while vital hepatitis is the commonest cause world-wide, Cerebral oedema is the leading cause of death in patients with ALF. Despite advances in intensive care and the development of new treatment modalities, ALF remains a condition of high mortality best managed in specialist centres. Orthotopic liver transplantation is the only new treatment modality that has made a significant impact in improving outcome. Bioartificial liver support systems and hepatocyte transplantation are new promising treatment options that may change the management of ALF in the future.
Original language | English |
---|---|
Pages (from-to) | 405-418 |
Number of pages | 14 |
Journal | Alimentary Pharmacology and Therapeutics |
Volume | 12 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1998 |
Externally published | Yes |